Aurinia Pharmaceuticals Inc. (AUPH) |
|
6.19 0.07 (1.14%)
|
02-22 16:00 |
|
Open: |
6.13 |
Pre. Close: |
6.12 |
|
High:
|
6.25 |
Low:
|
6 |
|
Volume:
|
507,217 |
Market Cap:
|
526M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.256 - 6.286 |
6.286 - 6.312 |
|
Low:
|
5.929 - 5.963 |
5.963 - 5.993 |
|
Close:
|
6.138 - 6.192 |
6.192 - 6.239 |
|
|
|
Technical analysis |
as of: 2019-02-22 4:40:09 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 8.21  One year: 8.96 |
| Support: |
Support1: 6.00 Support2: 4.99 |
| Resistance: |
Resistance1: 7.03 Resistance2: 7.67 |
| Pivot: |
6.45 |
| Moving Average: |
MA(5): 6.29 MA(20): 6.39
MA(100): 6.11 MA(250): 5.77 |
| MACD: |
MACD(12,26): -0.09 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 17.60 %D(3): 25.43 |
| RSI: |
RSI(14): 43.75 |
| 52-week: |
High: 7.85 Low: 5.01 Change(%): 10.5 |
| Average Vol(K): |
3-Month: 99293 10-Days: 51010 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.AUPH has closed above bottom band by 16.1%. Bollinger Bands are 38.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 12 Feb 2019 19:37:06 Z
Financial Exchange Stock Talk: Joe McCann On Aurinia Pharmaceuticals
Wed, 30 Jan 2019 20:54:34 Z
Is Aurinia Pharmaceuticals a Buy?
Tue, 22 Jan 2019 13:56:29 Z
Pre-Market Most Active for Jan 22, 2019 : SQQQ, EBAY, AUPH, MDWD, QQQ, TQQQ
Fri, 11 Jan 2019 04:30:00 Z
9 Pharma Stocks To Watch This Month
Thu, 08 Nov 2018 23:58:04 Z
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
85.50 |
| Shares Float (M) |
85.50 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
35.90 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.620 |
|
EPS Est. Current Year
|
-1.010 |
|
EPS Est. Next Year
|
-0.390 |
|
EPS Est. Next Quarter
|
-0.110 |
|
Forward EPS
|
-0.550 |
|
Book Value (p.s.)
|
4.400 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-11620.82 |
|
Return on Assets (ttm)
|
-29.7 |
|
Return on Equity (ttm)
|
-36.3 |
|
Qtrly Rev. Growth
|
1193.1 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-46.93 |
|
Levered Free Cash Flow (M)
|
-28.38 |
Stock Valuations |
|
P/E
|
-9.98 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
1.41 |
|
P/S
|
52825456640.00 |
|
P/CF
|
-11.28 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2013-10-23 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
